Natural environments may cut hospitalization for patients with neurodegenerative diseases
Dec 30, 2022
The normalized difference vegetation index was negatively associated with hospitalization for Alzheimer’s disease and related dementia as well as Parkinson’s disease.
Congressional report slams FDA, drugmaker over approval of Alzheimer’s drug Aduhelm
Dec 29, 2022
The controversy over aducanumab (Aduhelm) stretches back to its June 2021 approval by the US Food and Drug Administration.
5α-reductase inhibitors linked to depression, but not dementia
Dec 29, 2022
The magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant.
Senior living celebrates ‘big wins’ in proposed $1.7 trillion omnibus package
By
Kimberly Bonvissuto
Dec 21, 2022
Senior living advocates are claiming “major victories” for the industry following the release of the proposed $1.7 trillion congressional year-end spending bill on Monday.
Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
PET changes similar for Alzheimer’s disease, Down syndrome
Dec 20, 2022
“This study shows that, although there are subtle differences, Alzheimer’s disease pathophysiology is similar among people with Down syndrome and people with autosomal dominant Alzheimer’s...
National Alzheimer’s plan supports research, COVID testing in assisted living
By
Kimberly Bonvissuto
Dec 20, 2022
Support for clinical trial research and improved COVID-19 testing in assisted living communities are part of the 2022 update to the National Plan to Address Alzheimer’s Disease, announced Monday.
More news for Tuesday, Dec. 13
By
Kimberly Bonvissuto
Dec 13, 2022
Lawmakers call for improved access to brain scans in diagnosing Alzheimer’s disease … Federal judge strikes down Montana vaccine choice law in healthcare settings … Juniper Communities receives SageCare...
More news for Wednesday, Dec. 7
By
Kimberly Bonvissuto
Dec 07, 2022
Operating environment for life plan communities expected to deteriorate in 2023: Fitch … UK on cusp of personalized Alzheimer’s therapies … Older adults stress less than twentysomethings: study …...
Study explores impact of FDA approval of aducanumab on trial participation
Dec 06, 2022
Individuals who were independently aware of the FDA decision demonstrated a reduced willingness to participate.